Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Analysis of Genetic Differences in Drug Disposition
Condition: Prostate Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer, Lymphoma
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT01441089
Sponsor: National Cancer Institute (NCI)
Phase:
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: All
Inclusion Criteria:
- Patients with cancer, other tumors, or tumor predisposition syndromes currently enrolled in NIH intramural research program therapeutic trials . Ability of patient to understand and be willing to sign the informed consent document. Must be greater than or equal to
Exclusion Criteria:
- N/A
View trial on ClinicalTrials.gov